Author： Ringe J.D.
Publisher： Springer Publishing Company
ISSN： 0020-9554
Source： Der Internist, Vol.49, Iss.4, 2008-03, pp. : 502-504
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The role of zoledronic acid in the management of osteoporosis
Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. :
Access to resources
Recommend
AT1-Blocker zur Postinfarkttherapie: VALIANT-Studie
By Hasenfuß G.
Der Internist, Vol. 45, Iss. 8, 2004-08 ,pp. :
Zoledronic acid: future potential use in rheumatology
Future Rheumatology, Vol. 1, Iss. 5, 2006-10 ,pp. :
Atorvastatin zur Primärprävention kardiovaskulärer Ereignisse: ASCOT-LLA-Studie
By März W.
Der Internist, Vol. 45, Iss. 3, 2004-03 ,pp. :